Yamada G, Nakane P K
Lab Invest. 1977 Jun;36(6):649-59.
Hepatitis B core antigen (HBcAg) and hepatitis B surface antigen (HBsAg) were localized in human liver tissues by the peroxidase-labeled antibody method at the light and electron microscopic levels. Several methods of fixation, staining, and inhibition of endogenous peroxidase activity were studied. The periodate-lysine-paraformaldehyde fixative effectively preserved the tissue structure and the antigenicity of both antigens, and the peroxidase-labeled Fab' fraction of IgG penetrated well into hepatocytes. HBcAg was present in nuclei, or cytoplasm of hepatic cells, or both. In nuclei, the antigen was found both in virus-like particles of approximately 20 nm. diameter and in nuclear ground substance. In the cytoplasm, the antigen was found on membrane-bound ribosomes and free polysomes, and also in the ground substance of the cytosol near ribosomes and around nuclear membranes, especially near nuclear pores. HBcAg-positive virus-like particles were also demonstrated sparsely or in clusters in the cytoplasm. HBsAg was not present in nuclei but was found in the perinuclear space and in cisternae of endoplasmic reticulum, and on nuclear, endoplasmic reticulum, and cell membranes of hepatic cells. HBsAg-positive 25- to 30-nm. wide tubular forms, round particles (probably cross-sections of tubular forms), and a few large particles of 40 to 50 nm. diameter were seen in cisternae. Such HBsAg-positive particles were also present in the intercellular space and in Disse's space. These findings suggest that HBcAg produced on the cytoplasmic ribosomes migrates through nuclear pores to the nucleus and is assembled into core particles there. These particles may then move through nuclear pores to the cytoplasm where they are invested with HBsAg-positive membrane in cisternae of endoplasmic reticulum or as they enter the endoplasmic reticulum. These virus particles are then released together with other HBsAg-positive forms into the intercellular space by reversed phagocytosis.
采用过氧化物酶标记抗体法,在光镜和电镜水平上对人肝组织中的乙肝核心抗原(HBcAg)和乙肝表面抗原(HBsAg)进行定位。研究了几种固定、染色及抑制内源性过氧化物酶活性的方法。高碘酸盐-赖氨酸-多聚甲醛固定剂能有效保存组织结构及两种抗原的抗原性,IgG的过氧化物酶标记Fab’片段能很好地穿透肝细胞。HBcAg存在于肝细胞核、细胞质或两者中。在细胞核中,抗原存在于直径约20nm的病毒样颗粒及核基质中。在细胞质中,抗原存在于膜结合核糖体和游离多聚核糖体上,也存在于核糖体附近及核膜周围的细胞质基质中,尤其是核孔附近。HBcAg阳性的病毒样颗粒在细胞质中也呈散在或成簇分布。HBsAg不存在于细胞核中,而是存在于核周间隙、内质网池以及肝细胞的核膜、内质网膜和细胞膜上。在内质网池中可见到宽25至30nm的HBsAg阳性管状结构、圆形颗粒(可能是管状结构的横截面)以及一些直径为40至50nm的大颗粒。这种HBsAg阳性颗粒也存在于细胞间隙和狄氏间隙中。这些发现提示,在细胞质核糖体上产生的HBcAg通过核孔迁移至细胞核并在那里组装成核心颗粒。然后这些颗粒可能通过核孔进入细胞质,在内质网池中或进入内质网时被包裹上HBsAg阳性膜。这些病毒颗粒随后通过逆向吞噬作用与其他HBsAg阳性形式一起释放到细胞间隙中。